Vis enkel innførsel

dc.contributor.authorGaudernack, Henrik Egeland
dc.contributor.authorHareide, Martine Mathia
dc.contributor.authorMiaskowski, Christine
dc.contributor.authorRitchie, Christine
dc.contributor.authorLøyland, Borghild
dc.contributor.authorGrov, Ellen Karine
dc.contributor.authorPaul, Steven M
dc.contributor.authorTorstveit, Ann Helen
dc.contributor.authorUtne, Inger
dc.date.accessioned2022-01-20T09:52:16Z
dc.date.available2022-01-20T09:52:16Z
dc.date.created2021-09-11T15:12:33Z
dc.date.issued2021
dc.identifier.citationEuropean Journal of Oncology Nursing. 2021, 54, 102029en_US
dc.identifier.issn1462-3889
dc.identifier.urihttps://hdl.handle.net/11250/2838430
dc.description.abstractPurpose Evaluate for differences in demographic and clinical characteristics between older oncology patients with low multimorbidity (<2 multimorbidities) and high multimorbidity (≥2 multimorbidities) and evaluate for differences in symptom occurrence, severity, and distress ratings between the two groups. Methods Symptoms of older oncology patients (n = 125) were assessed using the Memorial Symptom Assessment Scale prior to chemotherapy administration. Data were analyzed using t-tests for continuous variables and Chi-square or Fisher's exact tests for categorical variables. Results For the total sample, lack of energy and pain were the two most common symptoms. Compared to the low multimorbidity group, the high multimorbidity group had a higher number of symptoms and significantly higher occurrence rates for feeling nervous, difficulty sleeping, dry mouth, and pain. Compared to the low multimorbidity group, the high multimorbidity group had significantly higher severity ratings for pain, feeling sad, lack of energy, feeling drowsy, and worrying. For distress, the high multimorbidity group reported significantly higher ratings for pain, worrying, feeling sad, feeling nervous, and “I don't look like myself”. No differences were found in any demographic or clinical characteristics between the two multimorbidity groups. Conclusions Multimorbidity is associated with higher symptom occurrence, severity, and distress in older oncology patients. Our findings suggest that the symptoms with the highest severity ratings were not the most distressing. Clinicians should identify multimorbidities and assess symptoms prior to chemotherapy to identify patients at increased risk and initiate referrals for interventions.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.subjectOlder adultsen_US
dc.subjectCanceren_US
dc.subjectMultimorbidityen_US
dc.subjectComorbidityen_US
dc.subjectChemotherapyen_US
dc.titleSymptom experience of older oncology patients with low versus high levels of multimorbidity prior to chemotherapyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionacceptedVersionen_US
dc.source.articlenumber102029en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1016/j.ejon.2021.102029
dc.identifier.cristin1933471
dc.source.journalEuropean Journal of Oncology Nursingen_US
dc.source.volume54en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal